\newpage
\FloatBarrier
\begin{table}[!b]
\renewcommand{\arraystretch}{1.2}
\begin{center}
\small
\caption[Gene enrichment analysis of gene ontology (GO) terms of the \textit{Drosophila melanogaster} orthologs for the candidate outliers.]{Gene enrichment analysis of gene ontology (GO) terms of the \textit{Drosophila melanogaster} orthologs for the candidate outliers. Fifty-eight unique \textit{D. melanogaster} orthologs were identified for the 53 candidate \textit{Drosophila serrata} Line 9 outlier loci (Table~\ref{tab:Fit53outliers}). GO terms consist of three categories (Type): biological processes (BP), molecular function (MF) and cellular function (CF). The number of Sample loci were tested against the Background number of genes containing the GO term and were assess using a Fisherâ€™s Exact test and corrected using a 0.05 False Discovery Rate (FDR). Bold GO terms represent supergroups and are followed by the corresponding subgroup GO terms.}
\label{tab:DNAsuppGOterms}
\tiny
\begin{tabular}{clS[table-format=4.0]S[table-format=2.0]S[table-format=2.2]ccc}
\toprule
\textbf{Type} &\textbf{GO Term} &\textbf{Background} &\textbf{Sample} &\textbf{Expected} &\textbf{fold Enrichment} &\textbf{$P-$value} &\textbf{FDR $P-$value}\\
\midrule
BP & \textbf{mitochondrial ADP transmembrane transport (GO:0140021)} & 2 & 2 & 0.01 & $> 100$ & 5.36E-05 & 1.60E-02 \\
 & cellular process (GO:0009987) & 7238 & 34 & 22.00 & $1.55$ & 1.56E-04 & 2.38E-02 \\
 & purine-containing compound transmembrane transport (GO:0072530) & 2 & 2 & 0.01 & $> 100$ & 5.36E-05 & 1.49E-02 \\
 & nucleotide transmembrane transport (GO:1901679) & 3 & 2 & 0.01 & $> 100$ & 8.91E-05 & 1.74E-02 \\
 & nucleotide transport (GO:0006862) & 7 & 2 & 0.02 & $94.02$ & 3.18E-04 & 3.94E-02 \\
 & ADP transport (GO:0015866) & 2 & 2 & 0.01 & $> 100$ & 5.36E-05 & 1.67E-02 \\
 & purine ribonucleotide transport (GO:0015868) & 5 & 2 & 0.02 & $> 100$ & 1.86E-04 & 2.74E-02 \\
 & purine nucleotide transport (GO:0015865) & 5 & 2 & 0.02 & $> 100$ & 1.86E-04 & 2.69E-02 \\
 & adenine nucleotide transport (GO:0051503) & 4 & 2 & 0.01 & $> 100$ & 1.33E-04 & 2.21E-02 \\[1.5ex]
 & \textbf{mitochondrial ATP transmembrane transport (GO:1990544)} & 2 & 2 & 0.01 & $> 100$ & 5.36E-05 & 1.55E-02 \\
 & ATP transport (GO:0015867) & 2 & 2 & 0.01 & $> 100$ & 5.36E-05 & 1.74E-02 \\[1.5ex]
 & \textbf{negative regulation of mitochondrial outer membrane permeabilization}& 3 & 2 & 0.01 & $> 100$ & 8.91E-05 & 1.83E-02 \\ [-1ex]
 &\textbf{involved in apoptotic signalling pathway (GO:1901029)} &  &  &  & &  &  \\
 & regulation of cellular process (GO:0050794) & 3690 & 23 & 11.21 & $2.05$ & 1.45E-04 & 2.27E-02 \\
 & regulation of biological process (GO:0050789) & 4030 & 27 & 12.25 & $2.2$ & 3.10E-06 & 8.05E-03 \\
 & biological regulation (GO:0065007) & 4471 & 27 & 13.59 & $1.99$ & 3.76E-05 & 1.46E-02 \\
 & negative regulation of programmed cell death (GO:0043069) & 117 & 4 & 0.36 & $11.25$ & 4.78E-04 & 4.90E-02 \\
 & negative regulation of mitochondrial membrane permeability (GO:0035795) & 3 & 2 & 0.01 & $> 100$ & 8.91E-05 & 1.88E-02 \\
 & regulation of mitochondrial membrane permeability (GO:0046902) & 6 & 2 & 0.02 & $> 100$ & 2.48E-04 & 3.22E-02 \\
 & regulation of membrane permeability (GO:0090559) & 6 & 2 & 0.02 & $> 100$ & 2.48E-04 & 3.17E-02 \\
 & cellular component organization (GO:0016043) & 2644 & 18 & 8.03 & $2.24$ & 4.95E-04 & 4.94E-02 \\
 & negative regulation of membrane permeability (GO:1905709) & 3 & 2 & 0.01 & $> 100$ & 8.91E-05 & 1.69E-02 \\
 & regulation of mitochondrial outer membrane permeabilization involved in & 3 & 2 & 0.01 & $> 100$ & 8.91E-05 & 1.78E-02 \\[-1ex]
 & apoptotic signalling pathway (GO:1901028) &  &  &  & &  &  \\[1.5ex]
 & \textbf{positive regulation of stress fibre assembly (GO:0051496)} & 6 & 2 & 0.02 & $> 100$ & 2.48E-04 & 3.12E-02 \\
 & positive regulation of actin filament bundle assembly (GO:0032233) & 8 & 2 & 0.02 & $82.27$ & 3.97E-04 & 4.48E-02 \\
 & positive regulation of supramolecular fibre organization (GO:1902905) & 44 & 3 & 0.13 & $22.44$ & 3.82E-04 & 4.51E-02 \\
 & positive regulation of cytoskeleton organization (GO:0051495) & 47 & 3 & 0.14 & $21$ & 4.59E-04 & 4.90E-02 \\[1.5ex]
 & \textbf{tracheal pit formation in open tracheal system (GO:0035202)} & 10 & 3 & 0.03 & $98.72$ & 7.24E-06 & 7.05E-03 \\
 & system development (GO:0048731) & 1339 & 15 & 4.07 & $3.69$ & 5.03E-06 & 9.79E-03 \\
 & anatomical structure development (GO:0048856) & 2531 & 18 & 7.69 & $2.34$ & 2.10E-04 & 2.92E-02 \\
 & multicellular organism development (GO:0007275) & 2125 & 18 & 6.46 & $2.79$ & 1.99E-05 & 9.12E-03 \\
 & multicellular organismal process (GO:0032501) & 3331 & 22 & 10.12 & $2.17$ & 8.26E-05 & 1.84E-02 \\
 & anatomical structure morphogenesis (GO:0009653) & 1466 & 14 & 4.45 & $3.14$ & 6.93E-05 & 1.80E-02 \\[1.5ex]
 & \textbf{lymph gland plasmatocyte differentiation (GO:0035169)} & 7 & 2 & 0.02 & $94.02$ & 3.18E-04 & 3.87E-02 \\
 & post-embryonic animal organ development (GO:0048569) & 462 & 7 & 1.40 & $4.99$ & 4.69E-04 & 4.93E-02 \\
 & animal organ development (GO:0048513) & 1162 & 14 & 3.53 & $3.96$ & 5.07E-06 & 7.90E-03 \\[1.5ex]
 & \textbf{integrin-mediated signalling pathway (GO:0007229)} & 11 & 3 & 0.03 & $89.75$ & 9.20E-06 & 7.96E-03 \\
 & cell surface receptor signalling pathway (GO:0007166) & 311 & 7 & 0.95 & $7.41$ & 4.23E-05 & 1.57E-02 \\
 & signal transduction (GO:0007165) & 1000 & 12 & 3.04 & $3.95$ & 3.05E-05 & 1.25E-02 \\
 & signalling (GO:0023052) & 1198 & 14 & 3.64 & $3.85$ & 7.21E-06 & 8.02E-03 \\
 & cell communication (GO:0007154) & 1268 & 14 & 3.85 & $3.63$ & 1.38E-05 & 9.76E-03 \\
 & cellular response to stimulus (GO:0051716) & 1496 & 14 & 4.55 & $3.08$ & 8.63E-05 & 1.87E-02 \\
 & response to stimulus (GO:0050896) & 2530 & 20 & 7.69 & $2.6$ & 1.45E-05 & 8.06E-03 \\[1.5ex]
 & \textbf{cell-matrix adhesion (GO:0007160)} & 17 & 4 & 0.05 & $77.43$ & 4.20E-07 & 3.27E-03 \\
 & cell-substrate adhesion (GO:0031589) & 24 & 4 & 0.07 & $54.85$ & 1.41E-06 & 5.51E-03 \\
 & cell adhesion (GO:0007155) & 179 & 6 & 0.54 & $11.03$ & 1.83E-05 & 8.92E-03 \\[1.5ex]
 & \textbf{cardiac muscle tissue development (GO:0048738)} & 9 & 2 & 0.03 & $73.13$ & 4.84E-04 & 4.90E-02 \\
 & tissue development (GO:0009888) & 1005 & 13 & 3.05 & $4.26$ & 5.73E-06 & 7.44E-03 \\[1.5ex]
 & \textbf{regulation of wound healing (GO:0061041)} & 17 & 3 & 0.05 & $58.07$ & 2.84E-05 & 1.23E-02 \\
 & regulation of response to wounding (GO:1903034) & 33 & 3 & 0.10 & $29.92$ & 1.72E-04 & 2.58E-02 \\[1.5ex]
 & \textbf{fibroblast growth factor receptor signalling pathway (GO:0008543)} & 25 & 3 & 0.08 & $39.49$ & 8.04E-05 & 1.96E-02 \\
 & cellular response to fibroblast growth factor stimulus (GO:0044344) & 25 & 3 & 0.08 & $39.49$ & 8.04E-05 & 1.90E-02 \\
 & cellular response to growth factor stimulus (GO:0071363) & 45 & 4 & 0.14 & $29.25$ & 1.40E-05 & 9.07E-03 \\
 & response to chemical (GO:0042221) & 1093 & 13 & 3.32 & $3.91$ & 1.41E-05 & 8.46E-03 \\
 & response to growth factor (GO:0070848) & 46 & 4 & 0.14 & $28.61$ & 1.51E-05 & 7.87E-03 \\
 & cellular response to endogenous stimulus (GO:0071495) & 154 & 5 & 0.47 & $10.68$ & 1.13E-04 & 1.95E-02 \\
 & response to endogenous stimulus (GO:0009719) & 162 & 5 & 0.49 & $10.16$ & 1.42E-04 & 2.30E-02 \\
 & response to fibroblast growth factor (GO:0071774) & 25 & 3 & 0.08 & $39.49$ & 8.04E-05 & 2.02E-02 \\[1.5ex]
 & \textbf{epithelial cell morphogenesis (GO:0003382)} & 31 & 3 & 0.09 & $31.85$ & 1.45E-04 & 2.30E-02 \\
 & cell development (GO:0048468) & 1303 & 12 & 3.96 & $3.03$ & 3.76E-04 & 4.51E-02 \\
 & epithelium development (GO:0060429) & 930 & 10 & 2.83 & $3.54$ & 3.92E-04 & 4.56E-02 \\
 %~~~~~~~~~~~~~~~~~~~~~ GAP ~~~~~~~~~~~~~~~~~~~~~~~~~~~~%
 \bottomrule
 \end{tabular}
\end{center}
\end{table}
\FloatBarrier
 \newpage
 \begin{table}[!b]
\renewcommand{\arraystretch}{1.2}
\begin{center}
\small
\tiny
\begin{tabular}{clS[table-format=4.0]S[table-format=2.0]S[table-format=2.2]ccc}
\toprule
\textbf{Type} &\textbf{GO Term (\textit{cont.})} &\textbf{Background} &\textbf{Sample} &\textbf{Expected} &\textbf{fold Enrichment} &\textbf{$P-$value} &\textbf{FDR $P-$value}\\
\midrule
  %~~~~~~~~~~~~~~~~~~~~~ GAP ~~~~~~~~~~~~~~~~~~~~~~~~~~~~%
 BF & \textbf{compound eye morphogenesis (GO:0001745)} & 276 & 6 & 0.84 & $7.15$ & 1.90E-04 & 2.70E-02 \\
 & compound eye development (GO:0048749) & 346 & 7 & 1.05 & $6.66$ & 8.19E-05 & 1.88E-02 \\
 & eye development (GO:0001654) & 364 & 7 & 1.11 & $6.33$ & 1.12E-04 & 2.07E-02 \\
 & sensory organ development (GO:0007423) & 456 & 7 & 1.39 & $5.05$ & 4.34E-04 & 4.83E-02 \\
 & visual system development (GO:0150063) & 364 & 7 & 1.11 & $6.33$ & 1.12E-04 & 2.02E-02 \\
 & sensory system development (GO:0048880) & 364 & 7 & 1.11 & $6.33$ & 1.12E-04 & 1.98E-02 \\
 & eye morphogenesis (GO:0048592) & 285 & 6 & 0.87 & $6.93$ & 2.26E-04 & 2.98E-02 \\
 & sensory organ morphogenesis (GO:0090596) & 285 & 6 & 0.87 & $6.93$ & 2.26E-04 & 3.03E-02 \\
 & animal organ morphogenesis (GO:0009887) & 721 & 10 & 2.19 & $4.56$ & 4.94E-05 & 1.75E-02 \\[1.5ex]
 & \textbf{post-embryonic appendage morphogenesis (GO:0035120)} & 317 & 6 & 0.96 & $6.23$ & 3.95E-04 & 4.52E-02 \\
 & appendage morphogenesis (GO:0035107) & 328 & 6 & 1 & $6.02$ & 4.72E-04 & 4.90E-02 \\
 & appendage development (GO:0048736) & 336 & 7 & 1.02 & $6.86$ & 6.83E-05 & 1.84E-02 \\[1.5ex]
 & \textbf{imaginal disc-derived appendage morphogenesis (GO:0035114)} & 326 & 6 & 0.99 & $6.06$ & 4.57E-04 & 4.95E-02 \\[1.5ex]
 & \textbf{epithelial tube morphogenesis (GO:0060562)} & 460 & 7 & 1.4 & $5.01$ & 4.57E-04 & 5.01E-02 \\
 & morphogenesis of an epithelium (GO:0002009) & 578 & 9 & 1.76 & $5.12$ & 5.24E-05 & 1.77E-02 \\
 & tissue morphogenesis (GO:0048729) & 596 & 10 & 1.81 & $5.52$ & 9.79E-06 & 7.63E-03 \\
 & tube morphogenesis (GO:0035239) & 503 & 8 & 1.53 & $5.23$ & 1.26E-04 & 2.13E-02 \\
 & tube development (GO:0035295) & 696 & 9 & 2.12 & $4.26$ & 2.12E-04 & 2.90E-02 \\
 \midrule
MF & \textbf{phenylalanine 4-monooxygenase activity (GO:0004505)} & 2 & 2 & 0.01 & $> 100$ & 5.36E-05 & 1.43E-02 \\
 & oxidoreductase activity, acting on paired donors, with incorporation or 
 & 3 & 2 & 0.01 & $> 100$ & 8.91E-05 & 1.74E-02 \\[-1ex]
& reduction of molecular oxygen, reduced pteridine as one donor, and  &  &  &  & &  &  \\[-1ex]
& incorporation of one atom of oxygen (GO:0016714)  &  &  &  & &  &  \\[1.5ex]
 & \textbf{ATP:ADP antiporter activity (GO:0005471)} & 2 & 2 & 0.01 & $> 100$ & 5.36E-05 & 1.31E-02 \\
 & ADP transmembrane transporter activity (GO:0015217) & 3 & 2 & 0.01 & $> 100$ & 8.91E-05 & 1.64E-02 \\
 & ion transmembrane transporter activity (GO:0015075) & 484 & 9 & 1.47 & $6.12$ & 1.32E-05 & 9.72E-03 \\
 & ATP transmembrane transporter activity (GO:0005347) & 4 & 2 & 0.01 & $> 100$ & 1.33E-04 & 2.30E-02 \\
 & solute: anion antiporter activity (GO:0140323) & 6 & 2 & 0.02 & $> 100$ & 2.48E-04 & 3.83E-02 \\[1.5ex]
 & \textbf{integrin binding (GO:0005178)} & 19 & 3 & 0.06 & $51.96$ & 3.83E-05 & 1.25E-02 \\
 & cell adhesion molecule binding (GO:0050839) & 74 & 4 & 0.22 & $17.79$ & 8.82E-05 & 1.85E-02 \\[1.5ex]
 & \textbf{DNA-binding transcription factor binding (GO:0140297)} & 70 & 4 & 0.21 & $18.8$ & 7.18E-05 & 1.62E-02 \\[1.5ex]
 & \textbf{DNA-binding transcription activator activity (GO:0001216)} & 95 & 4 & 0.29 & $13.86$ & 2.22E-04 & 3.63E-02 \\[1.5ex]
 & \textbf{ligand-gated ion channel activity (GO:0015276)} & 143 & 6 & 0.43 & $13.81$ & 5.31E-06 & 5.20E-03 \\
 & ion channel activity (GO:0005216) & 259 & 7 & 0.79 & $8.89$ & 1.34E-05 & 7.90E-03 \\
 & inorganic molecular entity transmembrane transporter activity (GO:0015318) & 429 & 7 & 1.3 & $5.37$ & 3.02E-04 & 4.43E-02 \\
 & channel activity (GO:0015267) & 274 & 7 & 0.83 & $8.41$ & 1.92E-05 & 8.04E-03 \\
 & passive transmembrane transporter activity (GO:0022803) & 274 & 7 & 0.83 & $8.41$ & 1.92E-05 & 9.38E-03 \\
 & ligand-gated channel activity (GO:0022834) & 143 & 6 & 0.43 & $13.81$ & 5.31E-06 & 7.80E-03 \\
 & gated channel activity (GO:0022836) & 202 & 7 & 0.61 & $11.4$ & 2.76E-06 & 8.11E-03 \\[1.5ex]
 & \textbf{protein heterodimerization activity (GO:0046982)} & 127 & 5 & 0.39 & $12.96$ & 4.65E-05 & 1.37E-02 \\
 & protein dimerization activity (GO:0046983) & 276 & 7 & 0.84 & $8.35$ & 2.01E-05 & 7.37E-03 \\
 \midrule
CF & \textbf{cell-substrate junction (GO:0030055)} & 44 & 4 & 0.13 & $29.92$ & 1.29E-05 & 5.70E-03 \\
 & anchoring junction (GO:0070161) & 166 & 7 & 0.5 & $13.88$ & 7.79E-07 & 1.04E-03 \\
 & cell junction (GO:0030054) & 466 & 9 & 1.42 & $6.36$ & 9.82E-06 & 6.53E-03 \\
\bottomrule
\end{tabular}
\end{center}
\end{table}


% Type & GO Term (cont.) & Background & Sample & Expected & $fold Enrichment$ & P-value & FDR \\
%  &  &  &  &  & & 0.00E+00 &  P-value \\